- V
VitaKey Inc.
- Gwangseong Kim
Gwangseong Kim, PhD is a Principal Scientist with expertise in R&D, analytical methods, and formulation development. Kim has experience in leading projects related to nutraceuticals, oncology drugs, infectious diseases, and COVID-related treatments. With a background in biomedical engineering and chemical engineering, Kim has worked in various roles in companies such as VitaKey Inc., L.E.A.F. Pharmaceuticals, and Kytaro Inc. Kim's specialties include LC-MS/MS bioanalytical method development, drug formulation, and team management. Additionally, Kim has served as a CTO and has experience in launching start-up companies.
Org chart
Teams
Offices
VitaKey Inc.
VitaKey's technology platform provides for a wide range of advanced encapsulations triggered by desired pH levels or other stimuli. Our technology delivers targeted and time-controlled release of micronutrients, vitamins, probiotics, nutraceuticals, antioxidants, proteins and amino acids, and flavors, as well as excellent bioavailability. VitaKey’s technology can be applied at every link of the food chain. It offers limitless applications for precision nutrition in food and beverages for humans ranging from infant to elderly, including customized diets, as well as seeds and agriculture, pet food and animal feed. Additionally, the targeted and time-controlled release encapsulation technology can enhance desired flavors and aromas as well as suppress unpleasant tastes and odors.
